ClinicalTrials.Veeva

Menu

Effectivenes of Erector Spinae Plane Block in Percutaneous Nephrolithotomy?

A

Ankara City Hospital

Status

Unknown

Conditions

Postoperative Pain
Nephrolithotomy, Percutaneous
Erector Spinae Plane Block

Treatments

Procedure: erector spinae block

Study type

Interventional

Funder types

Other

Identifiers

NCT04474873
E1-20-315

Details and patient eligibility

About

This study investigates the effectiveness of the erector spinae plane block (ESPB) in pain management of patients undergoing PNL.

Full description

Although percutaneous nephrolithotomy(PNL) is a minimally invasive procedure, it causes severe postoperative pain due to dilatation of the renal capsule and parenchymal duct and peritubal distension of the nephrostomy tube. PNL-related pain has a limited response to oral and intravenous treatments. The primary aim of our study is to investigate the effectiveness of the erector spinae plane block (ESPB) in pain management of patients undergoing PNL.

Our secondary aim is determining if any possible clinical effect of ESPB in terms of serial peak expiratory flow measurements, postoperative agitation score of the patient (Riker Score), ambulation time, length of hospital stay.

Enrollment

3 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients undergoing PNL between 18-65 years old

Exclusion criteria

  • serious cardiac, respiratory, hepatic, renal or haemotologic disease
  • mental disorder and hearing problem
  • anxiety, depression and / or other psychiatric disorders
  • pregnancy
  • refusal of patient
  • Allergy or contraindications to drugs used in the study
  • ASA > 2 Inflammation or infection over injection site Obese patients BMI ≥35/

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

3 participants in 2 patient groups

Group 1:Conventional intravenous analgesia
No Intervention group
Description:
Conventional intravenous analgesia applied according to surgeon's preference
Group 2:ESPB
Active Comparator group
Description:
A 6-13 MHz linear probe was used for ultrasound-guided ESPB (Logiq e, General Electric, USA,) performed at the T11 level. The transverse process was detected by sliding the transducer 3-4 cm laterally from the midline, and after identification of the transverse process, a 20-gauge 100mm insulated echogenic needle (Vygon locoplex, France) was used
Treatment:
Procedure: erector spinae block

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems